Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03966014 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Different Amoxicillin Treatment Regimens in Erythema Migrans Patients

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not applicable to Phase 3
    • Enrollment target: 510 to 200
    • Interventions: Controls (Other), EM-amoxicillin 2 x 14 days (Drug), EM-amoxicillin 3 x 10 days (Drug), EM-amoxicillin 3 x 14 days (Drug) to Controls (Other), EM-amoxicillin 3 x 10 days (Drug), EM-amoxicillin 3 x 14 days (Drug)
    • Study arms: 4 to 3
    v8
  2. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2027v7
  3. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2025v6
  4. Primary completion date: Dec 31, 2021 to Dec 31, 2023
    • Study completion date: Dec 31, 2022 to Dec 31, 2023
    v5
  5. Study completion date: Dec 31, 2021 to Dec 31, 2022v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study title expanded, about 1 wordv3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare the efficacy of different amoxicilline treatment regimens in patients with erythema migrans.
Trial Details
NCT Number NCT03966014
Lead Sponsor University Medical Centre Ljubljana
Collaborators: University of Ljubljana School of Medicine, Slovenia
Conditions
(from sponsor)		 Erythema Migrans
Related terms Glossitis, Benign Migratory
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov